Open Date
12 Dec 2024
Close Date
16 Dec 2024
Listing Date
19 Dec 2024
Max Investment
₹1,90,047
Price Range
₹1265 - ₹1329
Lot Size
-
IPO Size
₹2497.92Cr
Exchange Symbols


Open Date
Close Date
Listing Date
Max Investment
Price Range
Lot Size
IPO Size
Exchange Symbols
Comprehensive one-stop platform with diversified offerings across the outpatient and inpatient care value chain serving key stakeholders such as patients, physicians, nurses and healthcare organizations.
Leveraging digital evolution, transformation and automation technologies to create sustained value based on outcomes delivered.
Strong brand driven by clinical thought leadership through IKS Advisory Board, a healthcare industry leadership forum, and partnerships with industry players and evident through multiple awards and recognitions.
Marquee large enterprise clientele that include academic medical centres and healthcare systems, multispecialty and single-specialty medical groups, ancillary healthcare organizations, value enablers, and other outpatient healthcare delivery organizations and client stickiness reflected in revenues from repeat clients of over 98% in the last three Fiscals.
We are a technology-enabled healthcare solutions provider and offer a care enablement platform assisting physician enterprises in the US, Canada and Australia, with a focus on the US markets. We offer a comprehensive platform that enables healthcare enterprises across outpatient and inpatient care. Our offerings include, Revenue Optimization Solutions, that enable healthcare organizations to generate, capture and optimize their revenue, improve operational efficiencies, and increase enterprise value through a cost-optimized, globalized, technologyenabled offering with on-demand scalability. Our Revenue Optimization Solutions are offered in the Pre-Visit Stage and include patient scheduling services and IKS EVE, at the Peri-Visit Stage and include clinical coding solutions and referral order management, at the Post Visit Stage that include Billing, Payment Posting, Denial Management, and Account Receivables Follow Up, IKS Optimix and at the In-Acute Settings Stage. We provide Clinical Support Solutions at each stage that include IKS Scribble, IKS Stacks, IKS AssuRx and IKS Migrate. In addition, we also provide clinical chart review and Hierarchical Condition Codes ("HCC") coding solutions which cater to our Value Based Care (VBC) portfolio. Our Unifying Data Platform solution enables healthcare organizations to ingest, aggregate, normalize, sort and clean clinical, financial and administrative data for a provider enterprise into a single enterprise data warehouse. We generate revenue from the sale of our services and offerings to clients. As of September 30, 2024, we served 778 US-based healthcare organizations. As of September 30, 2024.
Inventurus Knowl: IPO Dates
The Inventurus Knowl IPO opens for subscription on 12 Dec 2024, and closes on 16 Dec 2024. Investors will likely receive their allotment status updates on 17 Dec 2024. Those who get allotted shares can expect them credited to their Demat accounts by 18 Dec 2024. The shares will be officially listed on the stock exchange on 19 Dec 2024.
Inventurus Knowl: IPO Price Band
The IPO consists of a fresh issue and an offer for sale, with a price band set between ₹1265.0 and ₹1329.0 per share.Investors can apply within this range. This book-building issue includes a fresh issue worth ₹0.0 crore and an offer for sale valued at ₹ 2497.92 crore. The exact listing price will be revealed on 19 Dec 2024, which is when the shares start trading on the exchange.
Inventurus Knowl: Lot Size and Issue Size
The minimum application lot size is shares, and investors need to apply for at least one lot. The total IPO size is approximately ₹2497.92Cr crore.
You will also get notified of your allotment via push notifications and email from Torus Digital.

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Congratulations,
Your Digital savings bank account opening journey is complete.